Example: air traffic controller
PRODUCT MONOGRAPH INCLUDING PATIENT …
AFLURIA® TETRA (Inactivated Influenza Vaccine (Split Virion)) Product Monograph Page 1 of 24 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION AFLURIA® TETRA Quadrivalent Inactivated Influenza Vaccine (Split Virion) Suspension for Injection Active Immunizing Agent for the Prevention of Influenza ATC Code: J07BB02 2020 - 2021 Strains:
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
ENGERIX-B
pdf.hres.caPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ENGERIX-B Hepatitis B vaccine (recombinant) 0.5 mL and 1.0 mL suspensions of 20 mcg/mL hepatitis B surface antigen for injection Active immunizing agent against infection caused by all known subtypes of hepatitis B virus ATC Code: J07BC01 GlaxoSmithKline Inc. 7333 Mississauga Road
FLUZONE Quadrivalent
pdf.hres.caSanofi Pasteur Product Monograph 450/477 - FLUZONE® Quadrivalent Page 4 of 35 FLUZONE® Quadrivalent Influenza Virus Vaccine Quadrivalent Types A and B (Split Virion) PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Route of Administration: Intramuscular injection. Dosage Form/Strength: Suspension for injection.
PRODUCT MONOGRAPH GRAVOL
pdf.hres.caEar/Nose/Throat Dimenhydrinate may mask the presence of underlying organic abnormalities or the toxic effects of certain antibiotics and other drugs, particularly those drugs causing ototoxicity. Endocrine and Metabolism Use with caution in patients who are poor CYP2D6 metabolizers and in patients with thyroid dysfunction. Gastrointestinal
PRODUCT MONOGRAPH
pdf.hres.ca8.4 Post Market Adverse Reactions Table updated to as per the ... is a biosimilar biologic drug (biosimilar) to HERCEPTIN®. PART I: HEALTH PROFESSIONAL INFORMATION 1 INDICATIONS Indications have been granted on the basis of similarity between OGIVRI and the reference biologic drug ... OGIVRI (trastuzumab) can result in the development of ...
doses of 0.3 mL) Active Immunizing Agent Mainz, Rhineland ...
pdf.hres.cacomirnaty (covid-19 vaccine, mrna) product monograph page 2 of 53 recent major label changes 1. indications 11/2021 4. dosage and administration 11/2021 7. warnings and precautions 11/2021 table of contents
PRODUCT MONOGRAPH
pdf.hres.caPRODUCT MONOGRAPH Pr WELLBUTRIN ... incidence in clinical trials with doses of 450 mg/day was approximately 0.39% (2 of 537 subjects). There were no seizures in clinical trials where subjects (n=1638) were treated up to the maximum recommended dose of 300 mg/day. In post marketing data however, seizures have been observed across all doses and
PRODUCT MONOGRAPH
pdf.hres.caPRODUCT MONOGRAPH DUKORAL® Oral, Inactivated Cholera and ETEC Diarrhea Vaccine Oral Suspension Active Immunizing Agent for the Prevention of Diarrhea Caused by Vibrio cholerae and/or heat-labile toxin producing Enterotoxigenic Escherichia coli ATC Code: J07AE01 Manufactured by: Date of Approval: Valneva Sweden AB,
PRESCRIBING INFORMATION CYANOCOBALAMIN INJECTION, …
pdf.hres.caSupplied: Each ml contains: Cyanocobalamin 1,000 mcg, Sodium Acetate 0.5 mg, Glacial Acetic Acid 0.1 mg, Sodium Chloride 9.0 mg with Benzyl Alcohol 1.5 % as preservative in Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid may have been used to adjust pH . Multiple dose vials of 10 ml and 30mL.
FLUZONE High-Dose Quadrivalent
pdf.hres.casodium chloride solution. - traces of formaldehyde and ovalbumin. ... Quadrivalent does not contain latex (natural rubber). ... (Split Virion)] is a sterile aqueous suspension of inactivated influenza virus for intramuscular injection.
FLULAVAL TETRA (2021-2022)
pdf.hres.caEgg proteins, sodium deoxycholate, ethanol, formaldehyde, sucrose, -tocopheryl hydrogen succinate, polysorbate 80. Thimerosal preservative in the multidose presentation only. For a complete listing see Dosage Forms, Composition and Packaging section. *The prefilled syringe presentation is not available for the 2021- 2 season DESCRIPTION
Related documents
PRODUCT MONOGRAPH INCLUDING PATIENT …
www.astrazeneca.caProduct Monograph Master Template Template date: September 2020 FORXIGA (dapagliflozin propanediol monohydrate) Page 1of 75 COPYRIGHT 2014-2021 ASTRAZENECA CANADA INC PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION FORXIGA® Dapagliflozin propanediol monohydrate Tablets, 5 mg and 10 mg, Oral ATC Code: A10BK01
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.gsk.comPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ENGERIX-B Hepatitis B vaccine (recombinant) 0.5 mL and 1.0 mL suspensions of 20 mcg/mL hepatitis B surface antigen for injection Active immunizing agent against infection caused by allknown subtypes of hepatitis B virus ATC Code: J07BC01 GlaxoSmithKline Inc. 7333 Mississauga …
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.gsk.comPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION SHINGRIX Herpes Zoster vaccine (non-live recombinant, AS01B adjuvanted) Suspension for injection, 50 mcg Varicella Zoster Virus (VZV) glycoprotein E (gE), Intramuscular Injection Active Immunizing Agent GlaxoSmithKline Inc. 7333Mississauga Road Mississauga, Ontario L5N 6L4
PRODUCT MONOGRAPH INCLUDING PATIENT …
covid-vaccine.canada.caPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrCasirivimab and imdevimab for injection Solutions for infusion, each available as 1332 mg/11.1 mL and 300 mg/2.5 mL (120mg/mL) single-use vials Anti-SARS-CoV-2 spike protein monoclonal antibodies HEALTH CANADA HAS AUTHORIZED THE SALE OF THIS COVID-19 DRUG BASED ON …
PRODUCT MONOGRAPH INCLUDING PATIENT …
covid-vaccine.canada.caPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION SPIKEVAX™ Elasomeran mRNA vaccine Dispersion for intramuscular injection Multidose Vial, 100 mcg / 0.5mL Active Immunizing Agent Submission Control Number: 259289 ModernaTX, Inc. 200 Technology Square Cambridge, MA, USA, 02139 Imported and Distributed by: Innomar Strategies, Inc.
PRODUCT MONOGRAPH INCLUDING PATIENT …
www.novonordisk.caProduct Monograph OZEMPIC® semaglutide injection Page 1 of 56. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PROZEMPIC® semaglutide injection . 2 mg/pen (1.34 mg/mL) 4 mg/pen (1.34 mg/mL) Pre-filled pen delivering doses of 0.25 mg or 0.5 mg . and . Pre-filled pen delivering doses of 1 mg . ATC code: A10BJ06 ...
PRODUCT MONOGRAPH INCLUDING PATIENT …
www.caddra.caPRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . FOQUEST® methylphenidate hydrochloride . Controlled Release Capsules . 25 mg, 35 mg, 45 mg, 55 mg, 70 mg, 85 mg and 100 mg . Professed Standard . Central Nervous System Stimulant . Purdue Pharma 575 Granite Court
PATIENT MEDICATION INFORMATION - AstraZeneca
www.astrazeneca.caProduct Monograph Master Template Template date: September 2020 FORXIGA (dapagliflozin propanediol monohydrate) Page 1 of 8 COPYRIGHT 2014-2021 ASTRAZENECA CANADA INC PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PrFORXIGA Dapagliflozin tablets
Nivolumab Monograph - BC Cancer
www.bccancer.bc.caNivolumab SPECIAL PRECAUTIONS: Caution: • product contains 2.3 mg/mL sodium (0.1 mmol/mL); consider sodium content as needed for patients on a controlled sodium diet1 • avoid systemic corticosteroids or immunosuppressants prior to starting nivolumab due to potential interference with the efficacy of nivolumab; corticosteroids or immunosuppressants may be used during treatment with
Related search queries
PRODUCT MONOGRAPH INCLUDING PATIENT, Product Monograph, PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION, PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ENGERIX, PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION SHINGRIX, PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION, PATIENT MEDICATION INFORMATION, Monograph, Product